Scientists probe cancer cell resistance: new insights may help development of new drugs.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001549:Benzamides; D001943:Breast Neoplasms / Q000188:drug therapy; D019008:Drug Resistance, Neoplasm / Q000235:genetics / Q000502:physiology*; D005784:Gene Amplification / Q000187:drug effects; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D018832:Molecular Chaperones; D009154:Mutation; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects*; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D018832:Molecular Chaperones; D010879:Piperazines; D011743:Pyrimidines; D013629:Tamoxifen; D000068877:Imatinib Mesylate